{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:28:36Z","timestamp":1760149716129,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03AG071596","R21AG073919"],"award-info":[{"award-number":["R03AG071596","R21AG073919"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: We herein report two cases of sudden onset symptomatic pulmonary hypertension after coronavirus disease 2019 (COVID-19) vaccination. Case Summary: Pulmonary hypertension in previously healthy adult males occurred within three weeks of receiving the second dose of the Pfizer (BNT162b2) mRNA COVID-19 vaccine from different lots. Both patients experienced a sudden onset of severe fatigue and dyspnea on exertion with negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) testing. The diagnosis was made by serial transthoracic echocardiography in the first case and by both transthoracic echocardiography and right heart catheterization in the second. Both cases resulted in functional limitations and likely permanent organ damage. No evidence of pulmonary emboli was detected in either case. Discussion: Pulmonary hypertension is a serious disease characterized by damage to lung vasculature and restricted blood flow through narrowed arteries from the right to left heart. The onset of symptoms is typically insidious, progressive and incurable, leading to right heart failure and premature death. The World Health Organization (WHO) classifies pulmonary hypertension into five categories and recently re-defined it as a resting mean pulmonary artery pressure greater than 20 mmHg. Sudden onset pulmonary hypertension would only be expected in the settings of surgical pneumonectomy or massive pulmonary emboli with compromise of at least 50% of the lung vasculature. We present here two novel cases of sudden onset pulmonary hypertension without evidence of pulmonary emboli, both of which occurred after receiving a COVID-19 mRNA vaccine.<\/jats:p>","DOI":"10.3390\/diseases11030114","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:14:11Z","timestamp":1693822451000},"page":"114","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination"],"prefix":"10.3390","volume":"11","author":[{"given":"Robert D.","family":"Sullivan","sequence":"first","affiliation":[{"name":"U.S. Anesthesia Partners, Frederick, MD 21701, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliia V.","family":"Shults","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgetown University, Washington, DC 20007, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6689-0497","authenticated-orcid":false,"given":"Yuichiro J.","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20007, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106823","DOI":"10.1016\/j.vph.2020.106823","article-title":"SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells","volume":"137","author":"Suzuki","year":"2021","journal-title":"Vascul. Pharmacol."},{"key":"ref_2","first-page":"1169","article-title":"Right ventricular dysfunction and pulmonary hypertension in COVID-19: A meta-analysis of prevalence and its association with clinical outcome","volume":"18","author":"Oktaviono","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/aas.13819","article-title":"Acute pulmonary hypertension and short-term outcomes in severe COVID-19 patients needing intensive care","volume":"65","author":"Norderfeldt","year":"2021","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5603\/CJ.a2021.0159","article-title":"Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors","volume":"29","author":"Rossi","year":"2022","journal-title":"Cardiol. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/jor1010004","article-title":"SARS-CoV-2 spike protein and lung vascular cells","volume":"1","author":"Suresh","year":"2021","journal-title":"J. Respir."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.21037\/cdt.2017.12.01","article-title":"Imaging of acute pulmonary embolism: An update","volume":"8","author":"Moore","year":"2018","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"f3368","DOI":"10.1136\/bmj.f3368","article-title":"When a test is too good: How CT pulmonary angiograms find pulmonary emboli that do not need to be found","volume":"347","author":"Wiener","year":"2013","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1164\/rccm.202005-1671LE","article-title":"Pulmonary vascular pruning on computed tomography and risk of death in the Framingham Heart Study","volume":"203","author":"Synn","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e006345","DOI":"10.1161\/CIRCHEARTFAILURE.119.006345","article-title":"Right ventricular afterload sensitivity has been on my mind","volume":"12","author":"Pahuja","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13244-019-0695-9","article-title":"Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: A pictorial essay for the interventional radiologist","volume":"10","author":"Bryce","year":"2019","journal-title":"Insights Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejcts.2004.05.036","article-title":"Study on the late effect of pneumonectomy on right heart pressures using Doppler echocardiography","volume":"26","author":"Foroulis","year":"2004","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4471-4219-5_4","article-title":"Acute and chronic right ventricular failure","volume":"22","author":"Sayer","year":"2017","journal-title":"Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0002-9149(71)90116-0","article-title":"The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease","volume":"28","author":"McIntyre","year":"1971","journal-title":"Am. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s10554-021-02315-y","article-title":"Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: Insights from the KARUM hemodynamic database","volume":"37","author":"Venkateshvaran","year":"2021","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(85)80477-0","article-title":"Continuous wave Doppler determination of right ventricular pressure: A simultaneous Doppler-catheterization study in 127 patients","volume":"6","author":"Currie","year":"1985","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","first-page":"45","article-title":"Assessment of pulmonary artery pressure by echocardiography\u2014A comprehensive review","volume":"12","author":"Parasuraman","year":"2016","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2045894019888422","DOI":"10.1177\/2045894019888422","article-title":"Prognostic value of six-minute walk distance at a South American pulmonary hypertension referral center","volume":"10","author":"Costa","year":"2020","journal-title":"Pulm. Circ."},{"key":"ref_18","first-page":"269","article-title":"Brain natriuretic peptide in pulmonary arterial hypertension: Biomarker and potential therapeutic agent","volume":"3","author":"Casserly","year":"2009","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chest.2018.01.009","article-title":"Baseline and serial brain natriuretic peptide level predicts 5-year overall survival in patients with pulmonary arterial hypertension. Data from the REVEAL Registry","volume":"154","author":"Frantz","year":"2018","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41650","DOI":"10.1038\/srep41650","article-title":"Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension","volume":"7","author":"Tyrka","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"ytad353","DOI":"10.1093\/ehjcr\/ytad353","article-title":"Acute pulmonary hypertension due to microthrombus formation following COVID-19 vaccination: A case report","volume":"7","author":"Nakagawa","year":"2023","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Suzuki, Y.J., and Gychka, S.G. (2021). SARS-CoV-2 spike protein elicits cell signaling in human host cells: Implications for possible consequences of COVID-19 vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9010036"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","article-title":"Adverse effects of COVID-19 mRNA vaccines: The spike hypothesis","volume":"28","author":"Trougakos","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Parry, P.I., Lefringhausen, A., Turni, C., Neil, C.J., Cosford, R., Hudson, N.J., and Gillespie, J. (2023). \u2018Spikeopathy\u2019: COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082287"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/11\/3\/114\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:46:16Z","timestamp":1760129176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/11\/3\/114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["diseases11030114"],"URL":"https:\/\/doi.org\/10.3390\/diseases11030114","relation":{},"ISSN":["2079-9721"],"issn-type":[{"type":"electronic","value":"2079-9721"}],"subject":[],"published":{"date-parts":[[2023,9,4]]}}}